Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators... see more

TSX:QIPT - Post Discussion

Quipt Home Medical Corp > Sorry to see Quipt Downgrade - Ms. Stellick cut her target
View:
Post by besttobe on Nov 11, 2021 8:43am

Sorry to see Quipt Downgrade - Ms. Stellick cut her target

 Ms. Stellick cut her target for shares of Quipt 

More downgrades to come?
Comment by sebraz on Nov 11, 2021 8:49am
Downgrade from 13.40 to 13.20? wow. I might as well sell my entire position.
Comment by lscfa on Nov 11, 2021 10:02am
Lame idiot bashing.....
Comment by Trademark11 on Nov 12, 2021 5:20am
Carlito, you do realize that your 100MM revenue reference is in the rear view mirror at this point, right??.  Just like looking at the stock price 5 days ago.......
Comment by Hoover69 on Nov 11, 2021 11:03pm
And the winner of the most deceptive post of the day goes to B2B.  Pathetic. The change to her target is basically a rounding error ($13.40 to $13.25). She maintained her Buy rating. There are 12 analysts covering Quipt with a consensus rating of Buy and Upside of 70% to todays closing price.  We can smell your desperation B2B and it is not pretty.  Sad to watch.
Comment by Carlito3311 on Nov 12, 2021 1:33am
This post has been removed in accordance with Community Policy
Comment by lscfa on Nov 12, 2021 8:42am
IA forecasts $134 million revenue for F22, dumbass.....  
Comment by lscfa on Nov 12, 2021 9:07am
Avg analyst forecasts...    Revenue 2021 2022 Increase Quipt 128 163 27.3% Viemed 143 158 10.5% Apria 1140  ...more  
Comment by MrGaiiinz1986 on Nov 12, 2021 12:10pm
Just be careful not to post too many good synergies about the company that most of us already know, or B2B/Carlito will keep covering their shorts and push the SP up too fast on low volume..... GLTA and have a good weekend
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities